Work

Efficacy and Safety of Risankizumab in the Treatment of Crohn's Disease of the Pouch

Year: 2024

Type: article

Abstract: Risankizumab has shown efficacy in the treatment of moderate-to-severe Crohn's disease (CD). The use of risankizumab in the treatment of CD of the pouch has not been previously reported. Here, we have 10 patients with biologics exposed CD of the pouch treated with risankizumab. Some patients showed endoscopic improvement regarding inflammation with minimal clinical improvement. Our findings warrant further study to validate the efficacy and safety of risankizumab in the treatment of CD of the pouch.

Source: ACG Case Reports Journal

DOI: 10.14309/crj.0000000000001476

Authors: Nan Lan, Bo Shen

Institutions: NewYork–Presbyterian Hospital, Columbia University Irving Medical Center

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W4402024543

FWCI: 0.981

Cites: 7

Cited by: 4

Related to: 10